eli lilly and company zepbound

Eli Lilly, Zepbound

Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.

· 1d · on MSN

Eli Lilly’s stock jumps as Zepbound sales nearly triple at lower prices

· 1d

Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing

18hon MSN

Eli Lilly’s obesity and diabetes treatments fuel growth and spark bidding war

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

1don MSN

Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

New Walmart Partnership to Let Patients Buy Eli Lilly's Zepbound Without Insurance Hassles

Eli Lilly partners with Walmart to sell its weight-loss drug Zepbound nationwide, giving patients easier, insurance-free access through LillyDirect.

18h

Eli Lilly: The Price Upside Just Increased

Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.

16h

Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs

Eli Lilly hiked its outlook as sales soared for its popular weight-loss drugs Zepbound and Mounjaro. The company also recently announced a partnership with Walmart that will expand access to Zepbound ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results